… Combinations of inhaled corticosteroids (ICS) and long-acting bronchodilators are widely
used to … We utilized visual inspection of funnel plot to evaluate the risk of publication bias. …

… role of bronchodilation in the treatment of stable COPD. Citation13 Inhaled bronchodilators
are … The current work reflects on the benefit/risk of current inhaled medications in a point-by-…

… respirator and one without gloves, gown, or eye protection. None of the 103 HCWs tested for
… and unfiltered); 2.5 mL albuterol sulfate nebulized Aerosols measured by two aerodynamic …

… risk factors of dysphagia have different risk weights, so we used these weights to construct a
visual risk … perspective, the risk prediction model helps nursing staff identify high-risk groups, …

… , with onset of ocular and respiratory tract … , inhaled bronchodilators such as β-2-agonists
may assist those with bronchospasm and/or obstructive changes on lung function tests. Inhaled …

… This narrative review defines cardiopulmonary risk as the risk of serious respiratory and/or …
of inhaled bronchodilators alone or in combination appear to outweigh any potential risks […

… to replacing inhaled OTC epinephrine with inhaled OTC albuterol, … Albuterol: an adrenergic
agent for use in the treatment of … The effect of inhaled albuterol in moderate to severe asthma. …

… corticosteroids (ICSs) combined with long-acting bronchodilators are indicated for patients
with COPD … Finally, we could not find clear evidence of increased risk of sepsis, eye disorders, …

… to provide interpretable and visual explanations of individualized risk predictions, which …
uses to decrease inadequate oral bronchodilators and optimize inhaled treatments. The risk …

… and eye protection can be used for an entire shift if unsoiled. … similar or greater risk of
transmission than nebulized therapy. … to nebulized albuterol in the assessment of bronchodilator …